Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
lncRNA SNHG29-RPS-CYLD axis is mitochondrially localized and mediates apoptosis in rituximab-resistant DLBCL
Related
- Case Report: Effective use of rituximab in children with steroid-resistant/dependent idiopathic pulmonary hemosiderosis: description of two cases and literature review
- Cannabidiol impairs tumor-associated behaviors and modulates apoptosis- and autophagy-related pathways in cisplatin-resistant head and neck squamous cell carcinoma
- Interpreting long‐term response to rituximab in immune thrombocytopenia: Cohort construction, treatment attribution, and dynamic prognostication
- More tests, higher scores: Testing frequency and SDMT differences between natalizumab and rituximab
- Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia
BibTeX
@article{xu2026lncrna,
title = {{lncRNA SNHG29-RPS-CYLD axis is mitochondrially localized and mediates apoptosis in rituximab-resistant DLBCL}},
author = {Xin Xu and Xia Wang and Huifang He and Qingxiu Zhong and Xin Zheng and Chan Rong and Li Yang and Wenshuang Ding and Zhaoliang Tang and Ye Lei},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75877-3},
url = {https://www.nature.com/articles/s41598-026-75877-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - lncRNA SNHG29-RPS-CYLD axis is mitochondrially localized and mediates apoptosis in rituximab-resistant DLBCL
AU - Xin Xu
AU - Xia Wang
AU - Huifang He
AU - Qingxiu Zhong
AU - Xin Zheng
AU - Chan Rong
AU - Li Yang
AU - Wenshuang Ding
AU - Zhaoliang Tang
AU - Ye Lei
PY - 2026
DA - 2026/10/20
JO - Scientific Reports
DO - 10.1038/s41598-026-75877-3
UR - https://www.nature.com/articles/s41598-026-75877-3
SN - 2045-2322
ER -